You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
Downregulation of mir-133b-5p by rest promotes prostate cancer metastasis to bone by targeting tgf-β
- In: D25 What’s new in industry & science? Part 2 on Thursday, 6 September 2018, 09:20 -09:30
- At: Glasgow (Scotland) (2018)
- Type: Presentation
- By: TANG, Yubo (Department of Pharmacy, The First Affiliated Hospital, Sun Yat-sen University, China)
- Co-author(s): Yubo Tang: Department of Pharmacy, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Shuai Huang: Department of Orthopaedic Surgery, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
Dong Ren: Department of Orthopaedic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Peiheng He: Department of Orthopaedic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Xiao Chen: Department of Pharmacy, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China - Abstract:
Background
High avidity of bone metastasis is an important characteristic in prostate cancer (PCa). Downexpression of miR-133b-5p has been reported to be involved in the development, progression and recurrence in PCa. However, clinical significance and biological roles of miR-133b-5p in bone metastasis of PCa remains unclear.
Methods
We used
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026